GUPharma Expands DMPK Capabilities to Support Large-Scale Collaborations
To better serve its global pharmaceutical clients, GUPharma has significantly enhanced its drug metabolism and pharmacokinetics (DMPK) services. This expansion includes an addition of 25,000 sq. ft. of advanced laboratories, equipped with the latest in high-end automation technology, underscoring its commitment to cutting-edge research and client service.
Previous Post